[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_5713 

# __Vaccine distribution systems__

## Risks linked to this technology

* [Expansion of the study to different countries and sectors may lead to the global spread of covid-19 variants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4712.md)
* [Inadequate effect on reducing peak value of infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6482.md)
* [Lack of proven treatment for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19214.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Assaad_guidelines_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_399.md)
* [Cao_analysis_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_667.md)
* [Li_seeing_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_429.md)

